Respiratory effects of glutamate receptor antagonists in neonate and adult mammals

被引:25
|
作者
Borday, V
Foutz, AS [1 ]
Nordholm, L
Denavit-Saubié, M
机构
[1] CNRS, Inst Alfred Fessard, F-91198 Gif Sur Yvette, France
[2] Novo Nordisk AS, Div Pharmaceut, Malov, Denmark
关键词
respiration; NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline; dizocilpine; neonate; development; (Cat); (Mouse);
D O I
10.1016/S0014-2999(98)00160-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We determined the conditions (immaturity, species, anesthesia, receptor blockade selectivity) under which glutamate receptor blockade produces respiratory depression in mammals. In unrestrained 0- to 2-day-old neonate and adult mice and cats, ventilation was measured by the barometric method, before and after separate or sequential administration of a non-NMDA receptor antagonist, NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline, 2-200 mg kg(-1) in mice, 10-40 mg kg(-1) in cats), and a NMDA receptor antagonist, dizocilpine (3 mg kg(-1) in mice, 0.15-1.0 mg kg(-1) in cats). NBQX or dizocilpine alone did not decrease ventilation in awake adults, but NBQX strongly depressed ventilation in neonate awake mice and in adult anesthetized animals. Given together: dizocilpine and NBQX always profoundly depressed ventilation by producing a lethal apnea in neonate mice, and an apneustic pattern of breathing in adults of both species and in neonate cats. We conclude that blockade of either NMDA or non-NMDA receptors is innocuous in awake adults. The factors which may potentiate respiratory depression are (1) anesthesia, (2) immaturity, and (3) combined blockade of both receptors types. The mechanism of depression is species-dependent and age-dependent. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 50 条
  • [41] Differential effects of GABAA receptor antagonists in the control of respiratory neuronal discharge patterns
    Dogas, Z
    Krolo, M
    Stuth, EA
    Tonkovic-Capin, M
    Hopp, FA
    McCrimmon, DR
    Zuperku, EJ
    JOURNAL OF NEUROPHYSIOLOGY, 1998, 80 (05) : 2368 - 2377
  • [42] The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment
    Donald C. Rojas
    Journal of Neural Transmission, 2014, 121 : 891 - 905
  • [43] Therapeutic potential of novel glutamate receptor antagonists in migraine
    Andreou, Anna P.
    Goadsby, Peter J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (06) : 789 - 803
  • [44] The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment
    Rojas, Donald C.
    JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (08) : 891 - 905
  • [45] GLUTAMATE-RECEPTOR ANTAGONISTS IN CEREBRAL-ISCHEMIA
    MCCULLOCH, J
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1994, (43): : 71 - 79
  • [46] Development and therapeutic role of glutamate receptor antagonists.
    Leeson, PD
    Sharp, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 104 - MEDI
  • [47] Behavioral pharmacology of metabotropic glutamate 1 receptor antagonists
    De Vry, J
    Bayer, AG
    NEUROPHARMACOLOGY, 2002, 43 (02) : 284 - 284
  • [48] Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
    Vinokurova, Daria
    Zakharov, Andrey V.
    Lebedeva, Julia
    Burkhanova, Gulshat F.
    Chernova, Kseniya A.
    Lotfullina, Nailya
    Khazipov, Rustem
    Valeeva, Guzel
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [49] Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy
    Löscher, W
    PROGRESS IN NEUROBIOLOGY, 1998, 54 (06) : 721 - 741
  • [50] Combined Strategies for the Discovery of Ionotropic Glutamate Receptor Antagonists
    Chimirri, Alba
    De Luca, Laura
    Ferro, Stefania
    De Sarro, Giovanbattista
    Ciranna, Lucia
    Gitto, Rosaria
    CHEMMEDCHEM, 2009, 4 (06) : 917 - 922